Inactive Instrument
Enzymatica AB Stock Nasdaq Stockholm
Stocks
SE0003943620
Pharmaceuticals
OTC Markets Traded| Market Cap | 413M 369M 344M 312M 588M 39.92B 593M 4.13B 1.61B 20.3B 1.55B 1.52B 65.26B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 381M 340M 317M 288M 543M 36.81B 547M 3.81B 1.49B 18.72B 1.43B 1.4B 60.18B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.32% |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 27/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.32% | +3.00% | - | - | 42.09M | |
| +2.44% | +2.85% | +41.06% | +108.13% | 1,032B | |
| +1.40% | -2.06% | +37.27% | +63.54% | 614B | |
| +1.81% | +3.85% | +16.68% | +82.19% | 471B | |
| +0.48% | -1.54% | +63.30% | +36.90% | 350B | |
| +2.92% | +3.12% | +24.78% | +43.51% | 337B | |
| +2.42% | +0.05% | +14.13% | +36.19% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.08% | -2.16% | +39.55% | +51.88% | 218B | |
| +1.68% | -1.40% | +25.85% | +95.80% | 179B | |
| Average | +1.75% | -3.39% | +28.66% | +58.93% | 412.76B | |
| Weighted average by Cap. | +1.81% | -3.18% | +32.16% | +69.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 40.72M 37.99M 34.51M 64.99M 4.41B 65.48M 457M 178M 2.24B 171M 167M 7.21B | 53.9M 48.16M 44.93M 40.81M 76.87M 5.21B 77.44M 540M 211M 2.65B 202M 198M 8.52B |
| Net income | -53.18M -47.52M -44.33M -40.27M -75.84M -5.14B -76.4M -533M -208M -2.62B -200M -195M -8.41B | -51.89M -46.36M -43.26M -39.29M -74M -5.02B -74.55M -520M -203M -2.55B -195M -191M -8.21B |
| Net Debt | -73.01M -65.24M -60.86M -55.28M -104M -7.06B -105M -731M -286M -3.59B -274M -268M -11.55B | -32.11M -28.69M -26.77M -24.31M -45.79M -3.11B -46.13M -322M -126M -1.58B -121M -118M -5.08B |
Employees
-
Sector
Pharmaceuticals
Calendar
